Related Experiment Video

Updated: May 10, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Targeted therapies in the treatment of advanced hepatocellular carcinoma

Zhengyu Wei1, Cataldo Doria, Yuan Liu

  • 1Division of Surgical Research, Department of Surgery, Cooper University Hospital and Cooper Medical School of Rowan University, Camden, NJ.

Clinical Medicine Insights. Oncology
|June 14, 2013
PubMed

Insights

Hepatocellular carcinoma (HCC), a common liver cancer, has limited treatment options for advanced stages. This review highlights recent progress in targeted therapies, offering new hope for patients with advanced HCC.

Area of Science:

  • Hepatology
  • Oncology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer and a leading cause of cancer mortality globally.
  • Existing therapies for advanced HCC are insufficient, necessitating the development of novel treatment strategies.
  • The increasing incidence of HCC underscores the urgent need for effective systemic treatments.

Purpose of the Study:

  • To review recent advancements in clinical targeted treatments for advanced hepatocellular carcinoma (HCC).
  • To provide an overview of promising targeted therapies currently under investigation or approved for HCC.
  • To discuss the clinical significance and future directions of targeted therapy in advanced HCC management.

Main Methods:

  • Literature review of clinical trials and research studies on targeted therapies for HCC.
  • Analysis of data on approved and investigational targeted drugs for advanced HCC.
  • Synthesis of current knowledge on the efficacy and safety of targeted treatments.

Main Results:

  • Sorafenib represents a breakthrough, approved for advanced HCC treatment.
  • Several other targeted therapies have shown promise in clinical trials.
  • Targeted therapies are emerging as a key strategy for advanced HCC.

Conclusions:

  • Targeted therapy offers a promising avenue for improving outcomes in advanced HCC.
  • Continued research and clinical trials are crucial for developing more effective treatments.
  • Personalized medicine approaches may enhance the efficacy of targeted treatments for HCC.
Keywords:
hepatocellular carcinoma (HCC)signaling pathwaysorafenibtargeted therapytumor inhibitor

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...